Pfizer to buy Array Biopharma for $48 a share in cash

Pfizer to buy Array Biopharma for $48 a share in cash


Pfizer has agreed to acquire Array Biopharma for approximately $11.4 billion in cash, including debt.

Shares of Array Biopharma soared 59% in premarket trading on the news.

The boards of directors of both companies have approved the merger.

This is breaking news. Please check back for updates.



Source link

Close Menu
error: Content is protected !!